Apoptosis inhibitor expressed by macrophages tempers autoimmune colitis and the risk of colitis-based carcinogenesis in TCRα-/- mice

Journal of Clinical Immunology

Volumn 27, Issue 6, 2007, Pages 549-556

  Haruta, Ikuko ^a   Shibata, Noriyuki ^a   Kato, Yoichiro ^a   Tanaka, Masanori ^b   Kobayashi, Makio ^a   Oguma, Hidetoshi ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Hirosaki City Hospital   (Japan)

Author keywords

AIM; Colitic cancer; Dysplasia; IBD; TCR mice

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; C57BL MOUSE; CELL TRANSFORMATION; CHO CELL; CRICETULUS; FEMALE; GENETICS; HAMSTER; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; TUMOR CELL LINE; ULCERATIVE COLITIS;

ANIMALS; AUTOIMMUNE DISEASES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHO CELLS; COLITIS, ULCERATIVE; CRICETINAE; CRICETULUS; FEMALE; INHIBITOR OF APOPTOSIS PROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RISK FACTORS;

EID: 39649102790     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9110-2     Document Type: Article

References (34)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928-37.
2. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-82.
3. Bhan AK, Mizoguchi E, Mizoguchi A. New models of chronic interstitial inflammation. Curr Opin Gastroenterol 1994;10:633-8. (Pubitemid 24338536)
4. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999;169:195-207. (Pubitemid 29338733)
5. Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Naito M. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med 1999;189:413-22. (Pubitemid 29063262)
6. Haruta I, Kato Y, Hashimoto E,Minjares C, Kennedy S, Uto H, et al. Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages. J Biol Chem 2001;276:22910-4.
7. Kuwata K, Watanabe H, Jiang SY, Yamamoto T, Tomiyama-Miyaji C, Abo T, et al. AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice. Am J Pathol 2003;162:837-47. (Pubitemid 36237492)
8. Yusa S, Ohnishi S, Onodera T, Miyazaki T. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-β1. Eur J Immunol 1999;29:1086-93. (Pubitemid 29164153)
9. Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A, Bookout AL, et al. A role for the apoptosis inhibitory factor AIM/Sp α/Api6 in atherosclerosis development. Cell Metabolism 2005;1:201-13. (Pubitemid 43960602)
10. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004;119(2):299-309. (Pubitemid 39360910)
11. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 2004;101(51):17813-8. (Pubitemid 40051969)
12. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44. (Pubitemid 24294554)
13. Provenzale D, Kowdley KV, Arora S, Wong JB. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995;109:1188-96.
14. Eaden JA, Abrams KR, Mayberr J. The risk of colorectal cancer in ulcerative colitis: a metaanalysis. Gut 2001;48:526-35. (Pubitemid 32234798)
15. Wong NACS, Harrison DJ. Colorectal neoplasia in ulcerative colitis - recent advances. Histopathology 2001;39:211-34.
16. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287(1):G7-17.
17. Watanabe J, Natsume T, Kobayashi M. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma. Cancer Sci 2006;97(12):1410-6. (Pubitemid 44614995)
18. Ohkusa T, Okayasu I, Tokoi S, Araki A, Ozaki Y. Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion 1995;56:159-64.
19. Mitsuyama K, Toyonaga A, Sata M. Intestinal microflora as a therapeutic target in inflammatory bowel disease. J Gastroenterol 2002;37 Suppl 14:73-7. (Pubitemid 35385931)
20. Cummings GH, Macfarlane GT, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 2003;4:9-20. (Pubitemid 36442897)
21. Dianda L, Hanby AM,Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-αβ-deficient mice fail to develop colitis in theabsence of a microbial environment. Am J Pathol 1997;150:91-7. (Pubitemid 27027100)
22. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997;156:145-66. (Pubitemid 27197200)
23. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-6. (Pubitemid 28194656)
24. Haruta I, Hashimoto E, Kato Y, Miyakawa H, Shibata N, Kobayashi M, et al. Intrahepatic biliary epithelial cell damage and inflammation in portal tract associated with chronic colitis-harboring TCRα-/- mice. Hepatol Res 2006;34:3-8. (Pubitemid 43091869)
25. -/- mice. Autoimmunity 2007;40(5):372-9.
26. Hagiwara C, Tanaka M, Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 2002;17:758-64. (Pubitemid 34779736)
27. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3569-77.
28. Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003;52:1522-9. (Pubitemid 37176736)
29. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28-35. (Pubitemid 36054726)
30. Mazzucchelli L, Hauser C, Zgraggen K, Wagener HE, Hess MW, Laissue JA, et al. Expression of IL-8 gene in inflammatory bowel disease is related to histological grade of active inflammation. Am J Pathol 1994;144:997-1007. (Pubitemid 24160640)
31. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP. MCP-1 gene expression in intestinal epithelial cells and IBD mucosa. Gastroenterology 1995;108:40-50.
32. MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998;4(1):54-67. (Pubitemid 128699837)
33. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-3.
34. Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses. J Clin Invest 1996;98(4):1010-20. (Pubitemid 26293320)